Select Page

Basic information about the COVID-19 vaccines based on World Health Organization data (available here).

  • There are four main approaches to develop a vaccine against a virus, like SARS-CoV-2.
  • All methods rely on APCs (antigen presenting cells) to initiate the immune response. Once the APC identifies components of the virus, it triggers immune cells. These cells are then enabled to recognize and neutralize the virus.
  • Some vaccines also contain adjuvants to enhance the immune response, and RNA based vaccines are encapsulated into lipid nanoparticles to protect it and help it enter the body’s cells.

 

Share this article:

About the continuum for Biologics

Biologics

Expert process development and manufacturing services for a diversity of biotherapeutics.

Bioconjugate

Flexible development and GMP manufacturing capacities for antibody-drug conjugates.

Nanodrugs

Integrated services for challenging API from formulation and development to GMP manufacturing.